7 insiders reported 63 Form 4 transactions for Beam Therapeutics Inc. (BEAM) over the past 18 months (most recent 2026-07-29). Recent activity: Simon Amy (Chief Medical Officer) Sell 16,667 shares, Simon Amy (Chief Medical Officer) Sell 373 shares, Evans John M. (CEO) Buy 18,663 shares, Evans John M. (CEO) Buy 6,337 shares, Evans John M. (CEO) Sell 13,421 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-29 | Simon Amy | Chief Medical Officer | Sell | 16,667 | $429,037 |
| 2026-07-02 | Simon Amy | Chief Medical Officer | Sell | 373 | $12,954 |
| 2026-07-01 | Evans John M. | CEO | Buy | 18,663 | $12,504 |
| 2026-07-01 | Evans John M. | CEO | Buy | 6,337 | $6,527 |
| 2026-07-01 | Evans John M. | CEO | Sell | 13,421 | $471,528 |
| 2026-07-01 | Evans John M. | CEO | Sell | 11,579 | $415,824 |
| 2026-07-01 | Evans John M. | CEO | Buy | 25,000 | $25,750 |
| 2026-07-01 | Evans John M. | CEO | Sell | 23,100 | $791,482 |
| 2026-07-01 | Evans John M. | CEO | Sell | 1,900 | $66,203 |
| 2026-06-29 | FMR LLC | 10% Owner | Sell | 33,372 | $1.2M |
| 2026-06-29 | FMR LLC | 10% Owner | Sell | 251,488 | $8.9M |
| 2026-06-22 | Ciaramella Giuseppe | President | Buy | 29,000 | $29,870 |
| 2026-06-22 | Ciaramella Giuseppe | President | Buy | 6,505 | $4,358 |
| 2026-04-06 | Ciaramella Giuseppe | President | Sell | 11,810 | $290,290 |
| 2026-04-06 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 3,242 | $79,688 |
| 2026-04-06 | Simon Amy | Chief Medical Officer | Sell | 6,700 | $164,686 |
| 2026-04-06 | Evans John M. | CEO | Sell | 30,078 | $739,317 |
| 2026-04-06 | Bellon Christine | Chief Legal Officer | Sell | 5,956 | $146,398 |
| 2026-04-02 | Simon Amy | Chief Medical Officer | Buy | 31,750 | $0 |
| 2026-04-02 | Emany Sravan Kumar | Chief Financial Officer | Buy | 31,750 | $0 |
| 2026-04-02 | Cavanagh Bethany J | SVP, Finance and Treasurer | Buy | 20,000 | $0 |
| 2026-04-02 | Ciaramella Giuseppe | President | Buy | 40,000 | $0 |
| 2026-04-02 | Bellon Christine | Chief Legal Officer | Buy | 20,000 | $0 |
| 2026-04-01 | Evans John M. | CEO | Buy | 25,000 | $16,750 |
| 2026-04-01 | Evans John M. | CEO | Sell | 25,000 | $559,250 |
Source: SEC Form 4 filings · as of 2026-07-29